Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle counts and ratios are helpful in diagnosing hair loss types, but should be used with other specific features for accurate diagnosis.

The supplement effectively improved hair growth and reduced hair loss safely.

Dermoscopic features can help distinguish female androgenetic alopecia from telogen effluvium and healthy controls.

Early diagnosis and personalized treatment are crucial for managing hair loss in India.

AGA and TE can be differentiated by specific trichoscopic features, with AGA showing more variation in hair thickness in fronto-temporal areas.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

COVID-19 infection can significantly cause temporary hair loss.

Chronic telogen effluvium is a common hair loss condition with specific characteristics and treatment options.

Critically ill patients may experience temporary hair loss after a fever.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

CTE can distort results in hair growth trials, so exclude it carefully.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Changing estrogen levels during menopause might affect genes related to body rhythms and cause increased hair loss.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Low ferritin and zinc levels, as well as anemia, are linked to more severe hair loss in Egyptian children with chronic hair shedding.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

Washing test helps identify hair loss type, low iron levels significant.

Chronic telogen effluvium is a condition that causes ongoing hair shedding.

Amino acid supplements may not be necessary for all women with chronic hair loss.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.